Abstract:Objective The development and progression of many cancers may be related to SALL4, the role and molecular mechanism of which are unclear in colon adenocarcinoma (COAD). Methods The SALL4 expression in adjacent normal mucosa tissues and carcinoma tissues of patients with COAD was detected through bioinformatic analysis based on TCGA database and immunohistochemistry. Single-cell analysis showed that the expression of SALL4 in normal tissue was noticeably low. GSEA analysis suggested that the SALL4 upregulated the GO and pathway of growth and cancer development and downregulated metabolization pathway. The relationship between lymph node metastasis, histological grading, clinical staging, and the expression of SALL4 in carcinoma tissues was analyzed. The upregulated or downregulated SALL4 expression of COAD cell lines was established. The influence of SALL4 on COAD cells invasion and proliferation was detected using plate cloning assay and Transwell. The expressions of EMT-related proteins E-cadherin, N-cadherin, vimentin, and Twist were detected by Western blot. The EMT phenotype was analyzed by immunofluorescence. Results The study confirmed that the expression of SALL4 was upregulated in COAD and positively correlated with the degree of tumor differentiation, tumor staging, and metastasis. The overexpression of SALL4 was related to a poor prognosis, promoted the invasion and proliferation of colorectal cancer cells, and accelerated the occurrence of EMT, which was characterized by upregulation of Twist, vimentin, and N-cadherin expressions and downregulation of E-cadherin. The immunofluorescence staining confirmed the EMT phenotype. On the contrary, knocking out SALL4 gene reversed EMT, weakened cell proliferation and invasion, inhibited upregulation of Twist, vimentin, and N-cadherin expressions and downregulation of E-cadherin. Conclusion To sum up, TNM grading, histological grading, and lymphatic metastasis were significantly correlated with SALL4 in tumor tissues. SALL4 played a vital role in tumor proliferation, invasion, and tumor EMT and may be a novel target for COAD.

SALL4 Activates TGF-beta/SMAD Signaling Pathway to Induce EMT and Promote Gastric Cancer Metastasis

Influence of Up-Regulation of Notch Ligand DLL4 on Biological Behaviors of Human Gastric Cancer Cells.

The Invasion and Metastasis of Colon Adenocarcinoma (COAD) Induced by SALL4

SALL4, a Novel Marker for Human Gastric Carcinogenesis and Metastasis.

SALL4 Promotes Gastric Cancer Progression Via Hexokinase II Mediated Glycolysis

Up-Regulation Of Sall4 Is Associated With Survival And Progression Via Putative Wnt Pathway In Gastric Cancer

SALL4 promotes angiogenesis in gastric cancer by regulating VEGF expression and targeting SALL4/VEGF pathway inhibits cancer progression

Targeting SALL4 by Entinostat Inhibits the Malignant Phenotype of Gastric Cancer Cells by Reducing EMT Signaling

Sall4 is A New Target in Endometrial Cancer

SALL4 promotes the tumorigenicity of cervical cancer cells through activation of Wnt/β-catenin pathway via CTNNB1.

Effect of SALL4 on the Proliferation, Invasion and Apoptosis of Breast Cancer Cells

SALL4 in gastrointestinal tract cancers: upstream and downstream regulatory mechanisms

Inhibition of SALL4 Suppresses Carcinogenesis of Colorectal Cancer Via Regulating Gli1 Expression.

The new advance of SALL4 in cancer: Function, regulation, and implication

Inhibition of SALL4 Reduces Tumorigenicity Involving Epithelial-Mesenchymal Transition Via Wnt/β-catenin Pathway in Esophageal Squamous Cell Carcinoma

MAPK4 Silencing in Gastric Cancer Drives Liver Metastasis by Positive Feedback Between Cancer Cells and Macrophages.

The Expression of SALL4 in Patients with Gliomas: High Level of SALL4 Expression is Correlated with Poor Outcome

SALL4: an emerging cancer biomarker and target.

SALL4 Correlates with Proliferation, Metastasis, and Poor Prognosis in Prostate Cancer by Affecting MAPK Pathway.

ATG4A promotes tumor metastasis by inducing the epithelial-mesenchymal transition and stem-like properties in gastric cells.

Mir-16 Targets SALL4 to Repress the Proliferation and Migration of Gastric Cancer